Skip to main content

Peer Review reports

From: Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

Original Submission
19 Jun 2019 Submitted Original manuscript
12 Aug 2019 Reviewed Reviewer Report - Tao Xiao
14 Aug 2019 Reviewed Reviewer Report - Shenghui Zhang
13 Sep 2019 Author responded Author comments - Takahiro Maeda
Resubmission - Version 2
13 Sep 2019 Submitted Manuscript version 2
29 Oct 2019 Author responded Author comments - Takahiro Maeda
Resubmission - Version 3
29 Oct 2019 Submitted Manuscript version 3
Publishing
31 Oct 2019 Editorially accepted
12 Nov 2019 Article published 10.1186/s12885-019-6322-9

You can find further information about peer review here.

Back to article page